Global Muscle Relaxant Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • ID:PD038616
  • June 2019
  • GIR (Global Info Research)
                          

The Global Muscle Relaxant Drugs Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.

Muscle spasticity is caused by damage to the spinal cord or brain. Nerves in the brain and spinal cord help relax the muscles during the idle state. Conditions that affect the brain or spinal cord such as multiple sclerosis, cerebral palsy, and stroke can interfere with normal muscle relaxation, leading to involuntary muscle spasms. This will impair the ability to walk, work, sleep, or just function normally. The muscles can also become excessively tense and develop overactive or overresponsive reflexes. Severe cases can lead to deep disability, including an inability to straighten out joints. Muscle relaxant drugs are primarily used in conjunction with general anesthetics to achieve muscle relaxation during surgical interventions.

Scope of the Report:
Old age is associated with the loss of fibrous tissue, and reduced vascular and glandular network in the layers of skin. In the elderly population, the appearance and characteristics of the skin gets altered, leading to wrinkles, appearance of frown lines, dryness, pigmentary alteration, and sagging of the skin. Muscle relaxant-based procedures help in reducing skin aging, thus giving younger look to a person by revitalizing and tightening the skin.

The worldwide market for Muscle Relaxant Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.

This report focuses on the Muscle Relaxant Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

  •     Pfizer
  •     Allergan
  •     Ipsen Group
  •     Teva Pharmaceuticals
  •     Novartis
  •     Johnson & Johnson
  •     Takeda Pharmaceutical
  •     Sun Pharmaceutical
  •     Merz Pharma
  •     Mylan
  •     Fresenius Kabi
  •     Endo International
  •     Par Sterile Products
  •     Acorda Therapeutics
  •     SteriMax Inc
  •     Emcure Pharmaceuticals
  •     Upsher-Smith Laboratories
  •     Orient Pharma
  •     Daewoong Pharmaceutical

Market Segment by Regions, regional analysis covers
  •     North America (United States, Canada and Mexico)
  •     Europe (Germany, France, UK, Russia and Italy)
  •     Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  •     South America (Brazil, Argentina, Colombia etc.)
  •     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
  •     Skeletal Muscle Relaxant Drugs
  •     Facial Muscle Relaxant Drugs

Market Segment by Applications, can be divided into
  •     Hospital Pharmacies
  •     Retail Pharmacies
  •     Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Muscle Relaxant Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Muscle Relaxant Drugs, with price, sales, revenue and global market share of Muscle Relaxant Drugs in 2017 and 2018.
Chapter 3, the Muscle Relaxant Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Muscle Relaxant Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Muscle Relaxant Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Muscle Relaxant Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Muscle Relaxant Drugs Introduction
    1.2 Market Analysis by Type
        1.2.1 Skeletal Muscle Relaxant Drugs
        1.2.2 Facial Muscle Relaxant Drugs
    1.3 Market Analysis by Applications
        1.3.1 Hospital Pharmacies
        1.3.2 Retail Pharmacies
        1.3.3 Others
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2014-2024)
            1.4.1.2 Canada Market States and Outlook (2014-2024)
            1.4.1.3 Mexico Market States and Outlook (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2014-2024)
            1.4.2.2 France Market States and Outlook (2014-2024)
            1.4.2.3 UK Market States and Outlook (2014-2024)
            1.4.2.4 Russia Market States and Outlook (2014-2024)
            1.4.2.5 Italy Market States and Outlook (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2014-2024)
            1.4.3.2 Japan Market States and Outlook (2014-2024)
            1.4.3.3 Korea Market States and Outlook (2014-2024)
            1.4.3.4 India Market States and Outlook (2014-2024)
            1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2014-2024)
            1.4.4.2 Egypt Market States and Outlook (2014-2024)
            1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
            1.4.4.4 South Africa Market States and Outlook (2014-2024)
            1.4.4.5 Turkey Market States and Outlook (2014-2024)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Pfizer
        2.1.1 Business Overview
        2.1.2 Muscle Relaxant Drugs Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Pfizer Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.2 Allergan
        2.2.1 Business Overview
        2.2.2 Muscle Relaxant Drugs Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Allergan Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.3 Ipsen Group
        2.3.1 Business Overview
        2.3.2 Muscle Relaxant Drugs Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Ipsen Group Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.4 Teva Pharmaceuticals
        2.4.1 Business Overview
        2.4.2 Muscle Relaxant Drugs Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Teva Pharmaceuticals Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.5 Novartis
        2.5.1 Business Overview
        2.5.2 Muscle Relaxant Drugs Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Novartis Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.6 Johnson & Johnson
        2.6.1 Business Overview
        2.6.2 Muscle Relaxant Drugs Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Johnson & Johnson Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.7 Takeda Pharmaceutical
        2.7.1 Business Overview
        2.7.2 Muscle Relaxant Drugs Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Takeda Pharmaceutical Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.8 Sun Pharmaceutical
        2.8.1 Business Overview
        2.8.2 Muscle Relaxant Drugs Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 Sun Pharmaceutical Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.9 Merz Pharma
        2.9.1 Business Overview
        2.9.2 Muscle Relaxant Drugs Type and Applications
            2.9.2.1 Product A
            2.9.2.2 Product B
        2.9.3 Merz Pharma Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.10 Mylan
        2.10.1 Business Overview
        2.10.2 Muscle Relaxant Drugs Type and Applications
            2.10.2.1 Product A
            2.10.2.2 Product B
        2.10.3 Mylan Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.11 Fresenius Kabi
        2.11.1 Business Overview
        2.11.2 Muscle Relaxant Drugs Type and Applications
            2.11.2.1 Product A
            2.11.2.2 Product B
        2.11.3 Fresenius Kabi Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.12 Endo International
        2.12.1 Business Overview
        2.12.2 Muscle Relaxant Drugs Type and Applications
            2.12.2.1 Product A
            2.12.2.2 Product B
        2.12.3 Endo International Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.13 Par Sterile Products
        2.13.1 Business Overview
        2.13.2 Muscle Relaxant Drugs Type and Applications
            2.13.2.1 Product A
            2.13.2.2 Product B
        2.13.3 Par Sterile Products Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.14 Acorda Therapeutics
        2.14.1 Business Overview
        2.14.2 Muscle Relaxant Drugs Type and Applications
            2.14.2.1 Product A
            2.14.2.2 Product B
        2.14.3 Acorda Therapeutics Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.15 SteriMax Inc
        2.15.1 Business Overview
        2.15.2 Muscle Relaxant Drugs Type and Applications
            2.15.2.1 Product A
            2.15.2.2 Product B
        2.15.3 SteriMax Inc Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.16 Emcure Pharmaceuticals
        2.16.1 Business Overview
        2.16.2 Muscle Relaxant Drugs Type and Applications
            2.16.2.1 Product A
            2.16.2.2 Product B
        2.16.3 Emcure Pharmaceuticals Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.17 Upsher-Smith Laboratories
        2.17.1 Business Overview
        2.17.2 Muscle Relaxant Drugs Type and Applications
            2.17.2.1 Product A
            2.17.2.2 Product B
        2.17.3 Upsher-Smith Laboratories Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.18 Orient Pharma
        2.18.1 Business Overview
        2.18.2 Muscle Relaxant Drugs Type and Applications
            2.18.2.1 Product A
            2.18.2.2 Product B
        2.18.3 Orient Pharma Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.19 Daewoong Pharmaceutical
        2.19.1 Business Overview
        2.19.2 Muscle Relaxant Drugs Type and Applications
            2.19.2.1 Product A
            2.19.2.2 Product B
        2.19.3 Daewoong Pharmaceutical Muscle Relaxant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Muscle Relaxant Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
    3.1 Global Muscle Relaxant Drugs Sales and Market Share by Manufacturer (2017-2018)
    3.2 Global Muscle Relaxant Drugs Revenue and Market Share by Manufacturer (2017-2018)
    3.3 Market Concentration Rate
        3.3.1 Top 3 Muscle Relaxant Drugs Manufacturer Market Share in 2018
        3.3.2 Top 6 Muscle Relaxant Drugs Manufacturer Market Share in 2018
    3.4 Market Competition Trend
4 Global Muscle Relaxant Drugs Market Analysis by Regions
    4.1 Global Muscle Relaxant Drugs Sales, Revenue and Market Share by Regions
        4.1.1 Global Muscle Relaxant Drugs Sales and Market Share by Regions (2014-2019)
        4.1.2 Global Muscle Relaxant Drugs Revenue and Market Share by Regions (2014-2019)
    4.2 North America Muscle Relaxant Drugs  Sales and Growth Rate (2014-2019)
    4.3 Europe Muscle Relaxant Drugs  Sales and Growth Rate (2014-2019)
    4.4 Asia-Pacific Muscle Relaxant Drugs  Sales and Growth Rate (2014-2019)
    4.5 South America Muscle Relaxant Drugs  Sales and Growth Rate (2014-2019)
    4.6 Middle East and Africa Muscle Relaxant Drugs  Sales and Growth Rate (2014-2019)
5 North America Muscle Relaxant Drugs by Country
    5.1 North America Muscle Relaxant Drugs Sales, Revenue and Market Share by Country
        5.1.1 North America Muscle Relaxant Drugs Sales and Market Share by Country (2014-2019)
        5.1.2 North America Muscle Relaxant Drugs Revenue and Market Share by Country (2014-2019)
    5.2 United States Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    5.3 Canada Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    5.4 Mexico Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
6 Europe Muscle Relaxant Drugs by Country
    6.1 Europe Muscle Relaxant Drugs Sales, Revenue and Market Share by Country
        6.1.1 Europe Muscle Relaxant Drugs Sales and Market Share by Country (2014-2019)
        6.1.2 Europe Muscle Relaxant Drugs Revenue and Market Share by Country (2014-2019)
    6.2 Germany Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    6.3 UK Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    6.4 France Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    6.5 Russia Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    6.6 Italy Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Muscle Relaxant Drugs by Country
    7.1 Asia-Pacific Muscle Relaxant Drugs Sales, Revenue and Market Share by Country
        7.1.1 Asia-Pacific Muscle Relaxant Drugs Sales and Market Share by Country (2014-2019)
        7.1.2 Asia-Pacific Muscle Relaxant Drugs Revenue and Market Share by Country (2014-2019)
    7.2 China Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    7.3 Japan Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    7.4 Korea Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    7.5 India Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    7.6 Southeast Asia Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
8 South America Muscle Relaxant Drugs by Country
    8.1 South America Muscle Relaxant Drugs Sales, Revenue and Market Share by Country
        8.1.1 South America Muscle Relaxant Drugs Sales and Market Share by Country (2014-2019)
        8.1.2 South America Muscle Relaxant Drugs Revenue and Market Share by Country (2014-2019)
    8.2 Brazil Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    8.3 Argentina Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    8.4 Colombia Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Muscle Relaxant Drugs by Countries
    9.1 Middle East and Africa Muscle Relaxant Drugs Sales, Revenue and Market Share by Country
        9.1.1 Middle East and Africa Muscle Relaxant Drugs Sales and Market Share by Country (2014-2019)
        9.1.2 Middle East and Africa Muscle Relaxant Drugs Revenue and Market Share by Country (2014-2019)
    9.2 Saudi Arabia Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    9.3 Turkey Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    9.4 Egypt Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    9.5 Nigeria Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
    9.6 South Africa Muscle Relaxant Drugs Sales and Growth Rate (2014-2019)
10 Global Muscle Relaxant Drugs Market Segment by Type
    10.1 Global Muscle Relaxant Drugs Sales, Revenue and Market Share by Type (2014-2019)
        10.1.1 Global Muscle Relaxant Drugs Sales and Market Share by Type (2014-2019)
        10.1.2 Global Muscle Relaxant Drugs Revenue and Market Share by Type (2014-2019)
    10.2 Skeletal Muscle Relaxant Drugs Sales Growth and Price
        10.2.1 Global Skeletal Muscle Relaxant Drugs Sales Growth (2014-2019)
        10.2.2 Global Skeletal Muscle Relaxant Drugs Price (2014-2019)
    10.3 Facial Muscle Relaxant Drugs Sales Growth and Price
        10.3.1 Global Facial Muscle Relaxant Drugs Sales Growth (2014-2019)
        10.3.2 Global Facial Muscle Relaxant Drugs Price (2014-2019)
11 Global Muscle Relaxant Drugs Market Segment by Application
    11.1 Global Muscle Relaxant Drugs Sales Market Share by Application (2014-2019)
    11.2 Hospital Pharmacies Sales Growth (2014-2019)
    11.3 Retail Pharmacies Sales Growth (2014-2019)
    11.4 Others Sales Growth (2014-2019)
12 Muscle Relaxant Drugs Market Forecast (2019-2024)
    12.1 Global Muscle Relaxant Drugs Sales, Revenue and Growth Rate (2019-2024)
    12.2 Muscle Relaxant Drugs Market Forecast by Regions (2019-2024)
        12.2.1 North America Muscle Relaxant Drugs Market Forecast (2019-2024)
        12.2.2 Europe Muscle Relaxant Drugs Market Forecast (2019-2024)
        12.2.3 Asia-Pacific Muscle Relaxant Drugs Market Forecast (2019-2024)
        12.2.4 South America Muscle Relaxant Drugs Market Forecast (2019-2024)
        12.2.5 Middle East and Africa Muscle Relaxant Drugs Market Forecast (2019-2024)
    12.3 Muscle Relaxant Drugs Market Forecast by Type (2019-2024)
        12.3.1 Global Muscle Relaxant Drugs Sales Forecast by Type (2019-2024)
        12.3.2 Global Muscle Relaxant Drugs Market Share Forecast by Type (2019-2024)
    12.4 Muscle Relaxant Drugs Market Forecast by Application (2019-2024)
        12.4.1 Global Muscle Relaxant Drugs Sales Forecast by Application (2019-2024)
        12.4.2 Global Muscle Relaxant Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Report 2019-2025

The Global Tigecycline Market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This report  read more..


Global Caffeine Market Research Report 2017

The Global Caffeine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure,  read more..


Global Rabies Vaccine Market Research Report 2017

The Global Rabies Vaccine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Research Report 2019

The Global Radiopharmaceuticals market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..